Neonatal and Pediatric Respiratory Care: What Does the Future Hold?

DiBlasi, Robert M; Cheifetz, Ira M.

doi:10.4187/respcare.01505

Cited by 6 publications

(4 citation statements)

References 80 publications

(66 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus young infants tolerate respiratory loads poorly and are susceptible to fatigue because of the immature pattern of their muscle fibers. 48,49 This explains why conventional CPT and increased-exhalation technique can be detrimental, and why these methods are no longer recommended.…”

Section: Chest Physical Therapymentioning

confidence: 99%

Chest Physical Therapy in Acute Viral Bronchiolitis: An Updated Review

2013

View full text Add to dashboard Cite

Section: Chest Physical Therapymentioning

confidence: 99%

Chest Physical Therapy in Acute Viral Bronchiolitis: An Updated Review

2013

View full text Add to dashboard Cite

“…The consequences of the disease and checkup must not be affected by the quick treatment for acute asthma in children. 29,30 Huge flow oxygen utilizing a snugly-fitting face mask must be utilized in children with lifethreatening asthma. The breathed β2 agonist salbutamol Table2.…”

Section: Clinical Guidelines In Emergency Departments For Children Suffering With Asthmamentioning

confidence: 99%

“…The examination must not delay children treated with an acute asthma exacerbation. Such elements are usually implemented through various team organs at 29,30 For children should be used huge flow oxygen of a snugly-fitting face mask with SpO2% <94% or life-threatening (LT) asthma. The saturation of oxygen should reach a rate of 94% to 98% (BTS/SIGN 2016).…”

Section: Clinical Guidelines In Emergency Departments For Children Suffering With Asthmamentioning

confidence: 99%

Clinical guidelines on pediatric asthma exacerbation in emergency department, a narrative review

Jafarnejad

Ebrahimi

2020

Eur J Transl Myol

View full text Add to dashboard Cite

Asthma has been known as a prevalent chronic-type inflammatory disease in children, because of their narrower respiratory airways. The present study aimed to identify guidelines for children asthma treatments. Extensive research was conducted on biomedical and pharmacological bibliographic database PubMed, EMBASE, MEDLINE, LILACS database, global independent network of Cochrane, Science Direct and global health library of Global Index Medicus. A comprehensive literature review was carried out using the terms Pediatric Asthma, epidemiology, management, and related clinical guidelines published from 2000 to 2019. After the primary assessment, quick diagnosis, clinical practice guidelines are useful tools for proper management of pediatric Asthma. By setting proper guidelines for this particular population, a higher improvement in quality of management of of pediatric Asthma is expected. Given the differences between the recommendations arisen by BTS/SIGN and NICE guidelines, critical comparison of the evidence-base guidelines provide suggestions that have more in common than what might seems at the first glance. The analysis of the variations presented in the present article will assist clinicians to make accurate decisions regarding their patients.

show abstract

“…As this treatment is most commonly used in preterm infants at risk of or with established RDS, this becomes an invasive procedure. Mechanical ventilation itself can result in lung injury [71], and noninvasive modes of ventilation are becoming more prevalent [72]. Thus, less invasive methods of surfactant delivery are being trialled.…”

Section: Recent Developments and Future Trendsmentioning

confidence: 99%

Pulmonary surfactant in newborn infants and children

Chakraborty

Kotecha

2013

Breathe

View full text Add to dashboard Cite

N To understand the composition, secretory pathways and functions of pulmonary surfactant.N To review the clinical evidence regarding the use of surfactants in newborn infants and children.N To develop an understanding of rarer disorders of surfactant metabolism. N To understand recent developments and future prospects in the field of surfactants. SummaryPulmonary surfactant is a complex mixture of specific lipids, proteins and carbohydrates, which is produced in the lungs by type II alveolar epithelial cells. The mixture is surface active and acts to decrease surface tension at the air-liquid interface of the alveoli. The presence of such molecules with surface activity had been suspected since the early 1900s and was finally confirmed in the mid-1900s. Since then, the chemical, physical and biological properties of the surfactant mixture have been revealed due to the work of several groups of investigators. The surfactant mixture is an essential group of molecules to support air breathing. Thus, preterm infants, who are born with immature lungs and are surfactant deficient, develop respiratory distress syndrome after being born. Replacement of natural surfactant therapy with purified surfactant from lungs of nonhuman species is one of the most significant advances in neonatology and has resulted in improved limits of viability of preterm infants. Although preterm infants are the primary population, exogenous surfactant treatment may also have a role to play in other respiratory diseases of term-born infants and older children. HERMES syllabus link: module E.1.16

show abstract

Neonatal and Pediatric Respiratory Care: What Does the Future Hold?

Cited by 6 publications

References 80 publications

Chest Physical Therapy in Acute Viral Bronchiolitis: An Updated Review

Chest Physical Therapy in Acute Viral Bronchiolitis: An Updated Review

Clinical guidelines on pediatric asthma exacerbation in emergency department, a narrative review

Pulmonary surfactant in newborn infants and children

Contact Info

Product

Resources

About